Publications by authors named "Panfeng Tan"

Claim this Profile
F
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.
Xiaohua Wu, Jing Wang, Danbo Wang, Guiling Li, Jieqing Zhang, Panfeng Tan

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trial.
Ying Cheng, Panpan Zhang, Ming Lu, Zhendong Chen, Lijie Song, Panfeng Tan

Cancer Immunol Immunother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial.
Hua Xu, Xin Yao, Zhisong He, Hong Luo, Guiling Li, Panfeng Tan

Target Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial.
Feng Wang, Lin Shen, Weijian Guo, Tianshu Liu, Jin Li, Yong Tang, Panfeng Tan

Nat Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
Panpan Zhang, Zhendong Chen, Si Shi, Zhiping Li, Feng Ye, Panfeng Tan

Cancer Immunol Immunother· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial.
Panpan Zhang, Si Shi, Jianming Xu, Zhendong Chen, Lijie Song, Panfeng Tan

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases.
Ye Guo, Weijie Zhang, Jieer Ying, Yanqiao Zhang, Yueyin Pan, Panfeng Tan

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and complication rates of tension-free vaginal tape, transobturator tape, and tension-free vaginal tape-obturator in the treatment of female stress urinary incontinence in a medium- to long-term follow up. Meta-analysis of randomized controlled trials.
Pan-Feng Tan, Lu-Lu Yang, Ru-Biao Ou, Ping Tang, Wen-Jun Yang

Saudi Med J· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis